73-75
Ratio of male to female births in the offspring of BRCA1 and BRCA2 carriers
G. Chenevix-Trench, O. M. Sinilnikova, G. Suthers, N. Pandeya and S. Mazoyer, et al.
77-84
High prevalence of two BRCA1 mutations, 4154delA and 5382insC, in Latvia
Laima Tikhomirova, Olga Sinicka, Dagnija Smite, Janis Eglitis and Shirley V. Hodgson, et al.
85-88
The Tyr978X BRCA1 mutation: occurrence in non-Jewish Iranians and haplotype in French-Canadian and non-Ashkenazi Jews
Lluís Quintana-Murci, Inbar Gal, Tangiz Bakhan, Hélène Quach and S Hamid Sayar, et al.
89-96
A high frequency of germline BRCA1/2 mutations in western Sweden detected with complementary screening techniques
Annika Bergman, Anna Flodin, Yvonne Engwall, Eva L. Arkblad and Kerstin Berg, et al.
97-103
The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation
Kelly A. Metcalfe, Carrie Snyder, Jennifer Seidel, Danielle Hanna and Henry T. Lynch, et al.
105-113
Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort
Kelly-Anne Phillips, Phyllis N. Butow, Ailsa E. Stewart, Jiun-Horng Chang and Prue C. Weideman, et al.
115-119
Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients
Karin Landsbergen, Chris Verhaak, Floor Kraaimaat and Nicoline Hoogerbrugge
121-126
Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations
Amy Østertun Geirdal, Jon G. Reichelt, Alv A. Dahl, Ketil Heimdal and Lovise Mæhle, et al.
127-133
A comparison of the phenotype and genotype in adenomatous polyposis patients with and without a family history
Brindusa Truta, Brian A. Allen, Peggy G. Conrad, Vivian Weinberg and Glenn A. Miller, et al.
135-138
Abdominal desmoid in familial adenomatous polyposis presenting as a pancreatic cystic lesion
Lana N. Pho, Cheryl M. Coffin and Randall W. Burt
139-143
An unusual case of Turcot’s syndrome associated with ileal adenocarcinoma, intestinal non-Hodgkin’s lymphoma, and duodenal adenocarcinoma. Review of the classification and genetic basis of Turcot’s syndrome
H. R. Murphy, W. Taylor, A. Ellis and R. Sturgess
145-149
Screening for exonic copy number mutations at MSH2 and MLH1 by MAPH
Seyed Mohammad Akrami, Malcolm G. Dunlop, Susan M. Farrington, Ian M. Frayling and Fiona MacDonald, et al.
151-161
Referrals of patients to colorectal cancer genetics services in south-east Scotland
Susan Holloway, Mary Porteous, Roseanne Cetnarskyj, Robert Rush and Sally Appleton, et al.
163-167
Informing one’s family about genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a retrospective exploratory study
Ilse Mesters, Marlein Ausems, Sophie Eichhorn and Hans Vasen
169-175
SISE matters: the Sum of Information on Seventy-yr-old Equivalents measures pedigree information content when assessing the risk of HNPCC in a family
R. C. Green, J. R. McLaughlin and H. B. Younghusband
177-181
The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li–Fraumeni-like kindreds
Rina Siddiqui, Kenan Onel, Flavia Facio, Kedoudja Nafa and Louis Robles Diaz, et al.
183-186
The CHEK2 1100delC allele is not relevant for risk assessment in HNPCC and HBCC Spanish families
Ana Sánchez de Abajo, Miguel de la Hoya, Javier Godino, Vicente Furió and Alicia Tosar, et al.
187-190
APC and β-catenin protein expression patterns in HNPCC-related endometrial and colorectal cancers
Short communication
Reetta Kariola, Wael M. Abdel-Rahman, Miina Ollikainen, Ralf Butzow and Päivi Peltomäki, et al.
191-194
Letter to the editor
The BRCA1 exon 13 duplication in the Swedish population
Barbara Kremeyer, Maria Soller, Kristina Lagerstedt, Paula Maguire and Sylvie Mazoyer, et al.
195-206
Review
Measurement of psychological factors associated with genetic testing for hereditary breast, ovarian and colon cancers
Susan T. Vadaparampil, Mary Ropka and Michael E. Stefanek